Lessee, Operating Lease, Liability, to be Paid, Year Three in USD of Tvardi Therapeutics, Inc. from Q1 2019 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Summary
Tvardi Therapeutics, Inc. quarterly Lessee, Operating Lease, Liability, to be Paid, Year Three history and change rate from Q1 2019 to Q2 2024.
  • Tvardi Therapeutics, Inc. Lessee, Operating Lease, Liability, to be Paid, Year Three for the quarter ending 30 Jun 2024 was $1.36M.
Lessee, Operating Lease, Liability, to be Paid, Year Three, Quarterly (USD)
Lessee, Operating Lease, Liability, to be Paid, Year Three, YoY Quarterly Change (%)

Tvardi Therapeutics, Inc. Quarterly Lessee, Operating Lease, Liability, to be Paid, Year Three (USD)

Period Value YoY Chg Change % Date Report Filed
Q2 2024 $1.36M 30 Jun 2024 10-Q 14 Aug 2024
Q1 2024 $1.36M 31 Mar 2024 10-Q 13 May 2024
Q4 2023 $1.33M 31 Dec 2023 10-K 06 Mar 2024
Q3 2023 $1.33M 30 Sep 2023 10-Q 13 Nov 2023
Q3 2020 $1.31M +$47K +3.72% 30 Sep 2020 10-Q 09 Nov 2020
Q2 2020 $1.29M +$24K +1.9% 30 Jun 2020 10-Q 10 Aug 2020
Q1 2020 $1.29M +$24K +1.9% 31 Mar 2020 10-Q 11 May 2020
Q4 2019 $1.29M 31 Dec 2019 10-K 27 Feb 2020
Q3 2019 $1.26M 30 Sep 2019 10-Q 05 Nov 2019
Q2 2019 $1.26M 30 Jun 2019 10-Q 07 Aug 2019
Q1 2019 $1.26M 31 Mar 2019 10-Q 07 May 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.